A trial looking at lenvatinib and pembrolizumab for people with advanced solid tumours (LEAP-005)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Bile duct cancer, Biliary tree cancers, Bowel (colorectal) cancer, Brain (and spinal cord) tumours, Breast cancer, Ovarian cancer, Secondary cancers, Stomach cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for people with one of the following solid tumours:

breast cancer whose cells don’t have receptors for the protein Her2 and the hormones oestrogen and progesterone (triple negative breast cancer)
ovarian cancer
stomach cancer
bowel cancer
a type of brain tumour called glioblastoma multiforme (GBM)
bile duct cancer
gallbladder cancer

It is for people whose cancer continued to grow or spread to other parts of the body despite treatment (advanced solid tumours).

Recruitment start: 8 May 2019

Recruitment end: 9 January 2022